NASDAQ:CRBP | Free Cash Flow | Corbus Pharmaceuticals Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$25.57M$6,000.00-$25.58M
2025-12-31-$15.92M
2025-03-31-$16.42M$0.00-$16.42M
2024-12-31-$10.94M
2024-03-31-$7.97M
2023-12-31-$6.01M$0.00-$6.01M
2023-03-31-$15.11M$0.00-$15.11M
2022-12-31-$7.45M$0.00-$7.45M
2022-03-31-$10.62M$13,449.00-$10.63M
2021-12-31-$9.7M$54,172.00-$9.76M
2021-03-31-$21.81M
2020-12-31-$18.22M-$52,086.00-$18.28M
2020-03-31-$27.6M$463,605.00-$28.06M
2019-12-31-$22.56M$1.29M-$23.85M
2019-03-31$10.32M$73,615.00$10.24M
2018-12-31-$14.06M$249,754.00-$14.31M
2018-03-31-$1.6M$1.27M-$2.87M
2017-12-31-$9.11M$580,183.00-$9.69M
2017-03-31-$6.64M$40,131.00-$6.68M
2016-12-31-$5.48M$96,018.00-$5.57M
2016-03-31-$2.51M$65,322.00-$2.58M
2015-12-31-$881,022.00$93,001.00-$974,023.00
2015-03-31-$1.28M$1,727.00-$1.28M
2014-12-31-$1.32M$0.00-$1.32M
2014-03-31-$139,980.00
2013-12-31-$123,252.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$64.49M$7,000.00-$64.5M
2024-12-31-$41.79M$0.00-$41.79M
2023-12-31-$36.1M$0.00-$36.1M
2022-12-31-$37.54M$13,449.00-$37.56M
2021-12-31-$48.18M$54,172.00-$48.24M
2020-12-31-$99.69M$484,491.00-$100.17M
2019-12-31-$45.72M$2.74M-$48.46M
2018-12-31-$30.07M$2.3M-$32.37M
2017-12-31-$27.8M$707,429.00-$28.5M
2016-12-31-$13.57M$353,032.00-$13.92M
2015-12-31-$4.62M$114,037.00-$4.74M
2014-12-31-$2.36M$64,448.00-$2.43M
2013-12-31-$366,715.00